US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VictoryShares Pioneer Asset-Based Income ETF

24.94

0.0000

Post-market: 24.940.00000.00%16:04 EST

Volume:11.00

Turnover:274.34

Market Cap:55.49M

PE:- -

High:24.94

Open:24.94

Low:24.94

Close:24.94

52wk High:25.27

52wk Low:24.89

Shares:2.23M

Float Shares:2.23M

Volume Ratio:0.29

T/O Rate:0.00%

Dividend:0.50

Dividend Rate:2.01%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Is the Future still Bright?

Calculated Risk

Salary sacrifice cuts could damage retirement savings

Assembly Biosciences announces Phase 1b data for ABI-4334

Assembly Biosciences Presents Positive Phase 1b Data for Next-Generation Capsid Assembly Modulator ABI-4334 at AASLD The Liver Meeting®

2026 US Economic Boost? Leading Indicators Point to "Data Center Construction Boom"

Assembly Biosciences’ ABI-6250 Study: A Potential Game-Changer in Hepatitis Treatment

AIA: "Softness persists at architecture firms" in September

Calculated Risk

Promising Phase 1b Results for ABI-5366 Drive Buy Rating for Assembly Biosciences

Assembly Biosciences Presents Interim Phase 1b Data for HSV Helicase-Primase Inhibitor Candidate ABI-5366 at the 38th Congress of the International Union Against Sexually Transmitted Infections (IUSTI)- Europe

Route1 Inc. Enhances ABI Software with New Revenue and Parking Capabilities

AIA: "Softness persists at architecture firms" in August

Calculated Risk

OSL Group Completes Acquisition of Licensed Indonesian Exchange Koinsayang

UK Insurers Gain Insight into Carbon Footprint of Claims with New Verisk Calculator

Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Study of Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366 Showing Reductions in Viral Shedding Rate and Genital Lesion Rate in Recurrent Genital Herpes

Assembly Biosciences Reports Interim Phase 1a Data from Clinical Study of Oral Entry Inhibitor Candidate ABI-6250 for Hepatitis Delta Virus

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ABI/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ABI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABI\",,,,,undefined,":{"symbol":"ABI","market":"US","secType":"STK","nameCN":"VictoryShares Pioneer Asset-Based Income ETF","latestPrice":24.94,"timestamp":1764709200000,"preClose":24.94,"halted":0,"volume":11,"hourTrading":{"tag":"盘后","latestPrice":24.94,"preClose":24.94,"latestTime":"16:04 EST","volume":3,"amount":74.82000000000001,"timestamp":1764709453093},"delay":0,"floatShares":2225000,"shares":2225000,"eps":0,"marketStatus":"Post-Mkt","change":0,"latestTime":"12-02 17:40:37 EST","open":24.94,"high":24.94,"low":24.94,"amount":274.3448,"amplitude":0,"askPrice":31.17,"askSize":200,"bidPrice":18.71,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1764723600000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":24.94,"sharesOutstanding":2225000,"nav":24.914643,"aum":55434985,"dividendRate":0.020088,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":24.94,"preClose":24.94,"latestTime":"16:04 EST","volume":3,"amount":74.82000000000001,"timestamp":1764709453093},"volumeRatio":0.286457},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABI\",,,,,undefined,":{"symbol":"ABI","floatShares":2225000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.286457,"shares":2225000,"dividePrice":0.501,"high":24.94,"amplitude":0,"preClose":24.94,"low":24.94,"week52Low":24.885,"pbRate":"--","week52High":25.27,"institutionHeld":0,"latestPrice":24.94,"eps":0,"divideRate":0.020088,"volume":11,"delay":0,"ttmEps":0,"open":24.94,"prevYearClose":25.08,"prevWeekClose":24.94,"prevMonthClose":24.94,"prevQuarterClose":25.035,"fiveDayClose":24.94,"twentyDayClose":24.975,"sixtyDayClose":25.17},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ABI\",params:#limit:5,,,undefined,":[{"date":"2025-11-07","symbol":"ABI","amount":0.122586,"announcedDate":"2025-11-06","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-11-07","defaultRemindTime":1762525800000,"name":"VictoryShares Pioneer Asset-Based Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-11-10","payableDate":"2025-11-07","currency":"USD","dateTimestamp":1762491600000,"payDate":"2025-11-10"},{"date":"2025-10-09","symbol":"ABI","amount":0.146893,"announcedDate":"2025-10-08","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-10-09","defaultRemindTime":1760016600000,"name":"VictoryShares Pioneer Asset-Based Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-10","payableDate":"2025-10-09","currency":"USD","dateTimestamp":1759982400000,"payDate":"2025-10-10"},{"date":"2025-09-08","symbol":"ABI","amount":0.132826,"announcedDate":"2025-09-05","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-08","defaultRemindTime":1757338200000,"name":"VictoryShares Pioneer Asset-Based Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-09","payableDate":"2025-09-08","currency":"USD","dateTimestamp":1757304000000,"payDate":"2025-09-09"},{"date":"2025-08-06","symbol":"ABI","amount":0.083425,"announcedDate":"2025-08-05","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-08-06","defaultRemindTime":1754487000000,"name":"VictoryShares Pioneer Asset-Based Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-07","payableDate":"2025-08-06","currency":"USD","dateTimestamp":1754452800000,"payDate":"2025-08-07"},{"date":"2025-07-10","symbol":"ABI","amount":0.01517,"announcedDate":"2025-07-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-07-10","defaultRemindTime":1752154200000,"name":"VictoryShares Pioneer Asset-Based Income ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-11","payableDate":"2025-07-10","currency":"USD","dateTimestamp":1752120000000,"payDate":"2025-07-11"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ABI\",market:\"US\",,,undefined,":[{"executeDate":"2025-07-10","recordDate":"2025-07-10","paymentDate":"2025-07-11","value":0.01517,"currency":"USD"},{"executeDate":"2025-08-06","recordDate":"2025-08-06","paymentDate":"2025-08-07","value":0.083425,"currency":"USD"},{"executeDate":"2025-09-08","recordDate":"2025-09-08","paymentDate":"2025-09-09","value":0.132826,"currency":"USD"},{"executeDate":"2025-10-09","recordDate":"2025-10-09","paymentDate":"2025-10-10","value":0.146893,"currency":"USD"},{"executeDate":"2025-11-07","recordDate":"2025-11-07","paymentDate":"2025-11-10","value":0.122586,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ABI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ABI\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2588057163","title":"Is the Future still Bright?","url":"https://stock-news.laohu8.com/highlight/detail?id=2588057163","media":"Calculated Risk","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588057163?lang=en_us&edition=fundamental","pubTime":"2025-12-02 11:34","pubTimestamp":1764646440,"startTime":"0","endTime":"0","summary":"It was almost thirteen years ago when I wrote \"The Future's so Bright …\"  I noted that I was the most optimistic since the '90s, and that things would only get better.I pointed out that housing starts would increase significantly over the next several years, that state and local governments would start hiring again, that the budget deficit would decline sharply, and that household deleveraging was nearing and an end.As I noted in January 2013: \"There are several tailwinds for the economy, and the headwinds  are mostly subsiding.\"Now these tailwinds have subsided. The significant growth for housing starts, new home sales and vehicle sales, is behind us.With the exception of data centers, commercial real estate is struggling, and some sectors - like hotels - are in recession. The Architecture Billings Index  has been in contraction for 35 of the last 37 months, suggesting a slowdown in CRE investment well into 2026.And the Federal budget deficit is increasing sharply.I'm not currently pr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"calculatedriskblog_highlight","url":"https://www.calculatedriskblog.com/2025/12/is-future-still-bright.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.calculatedriskblog.com/2025/12/is-future-still-bright.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"calculatedriskblog_highlight","symbols":["ABI"],"gpt_icon":0},{"id":"2583599693","title":"Salary sacrifice cuts could damage retirement savings","url":"https://stock-news.laohu8.com/highlight/detail?id=2583599693","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583599693?lang=en_us&edition=fundamental","pubTime":"2025-11-13 22:38","pubTimestamp":1763044692,"startTime":"0","endTime":"0","summary":"People are preparing to contribute less if salary sacrifice is changed  Brits will save less into their pensions if rumoured changes to salary sacrifice schemes are confirmed in the Budget, putting individual retirements and economic growth at risk.According to the Association of British Insurers , nearly 40 per cent of people will put less into their pension if Chancellor Rachel Reeves decided to cap salary sacrifice schemes at the end of the month.The schemes allow employees to give up a portion of their salary for other benefits, such as childcare vouchers, reducing total incomes and overall income tax bills.But for many the most popular salary sacrifice is pension schemes, which lets employees boost their pension contributions by agreeing to pay cuts.This pushes them back under the 100,000 threshold, and allows parents to keep their free childcare hours.While the Treasury scrambles to fill an estimated 20bn fiscal black hole, the uncertainty and speculation has caused further harm ","market":"nz","thumbnail":"https://www.cityam.com/wp-content/uploads/2024/10/01JBEPJFE6X7TX996CE16G4ER5-e1732189269346.jpg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2024/10/01JBEPJFE6X7TX996CE16G4ER5-e1732189269346.jpg?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/salary-sacrifice-cuts-could-damage-retirement-savings/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/salary-sacrifice-cuts-could-damage-retirement-savings/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["ABI"],"gpt_icon":0},{"id":"2581883120","title":"Assembly Biosciences announces Phase 1b data for ABI-4334","url":"https://stock-news.laohu8.com/highlight/detail?id=2581883120","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581883120?lang=en_us&edition=fundamental","pubTime":"2025-11-07 21:11","pubTimestamp":1762521075,"startTime":"0","endTime":"0","summary":"Assembly Biosciences (ASMB) announced Phase 1b clinical data for its next-generation investigational capsid assembly modulator, CAM, ABI-4334 featu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/assembly-biosciences-announces-phase-1b-data-for-abi-4334-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/assembly-biosciences-announces-phase-1b-data-for-abi-4334-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ABI","ASMB"],"gpt_icon":0},{"id":"2581388662","title":"Assembly Biosciences Presents Positive Phase 1b Data for Next-Generation Capsid Assembly Modulator ABI-4334 at AASLD The Liver Meeting®","url":"https://stock-news.laohu8.com/highlight/detail?id=2581388662","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581388662?lang=en_us&edition=fundamental","pubTime":"2025-11-07 21:00","pubTimestamp":1762520400,"startTime":"0","endTime":"0","summary":"– Phase 1b data demonstrating favorable safety and tolerability profile and potent reductions in viral nucleic acids highlighted in late-breaking poster presentation – SOUTH SAN FRANCISCO, Calif., Nov","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/07/3183614/16259/en/Assembly-Biosciences-Presents-Positive-Phase-1b-Data-for-Next-Generation-Capsid-Assembly-Modulator-ABI-4334-at-AASLD-The-Liver-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASMB","BK4588","HDV","CAM","BK4585","BK4139","ABI"],"gpt_icon":0},{"id":"1120370476","title":"2026 US Economic Boost? Leading Indicators Point to \"Data Center Construction Boom\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1120370476","media":"Deep News","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120370476?lang=en_us&edition=fundamental","pubTime":"2025-10-30 16:42","pubTimestamp":1761813757,"startTime":"0","endTime":"0","summary":"Key leading indicators for US non-residential construction suggest an impending wave of data center-led development, expected to peak in 2026 and potentially deliver significant economic momentum....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABI"],"gpt_icon":0},{"id":"2578621821","title":"Assembly Biosciences’ ABI-6250 Study: A Potential Game-Changer in Hepatitis Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2578621821","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578621821?lang=en_us&edition=fundamental","pubTime":"2025-10-28 01:17","pubTimestamp":1761585436,"startTime":"0","endTime":"0","summary":"Assembly Biosciences Inc (($ASMB)) announced an update on their ongoing clinical study. Assembly Biosciences Inc. is conducting a Phase 1a clinical...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/assembly-biosciences-abi-6250-study-a-potential-game-changer-in-hepatitis-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/assembly-biosciences-abi-6250-study-a-potential-game-changer-in-hepatitis-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABI","BK4139","ASMB"],"gpt_icon":0},{"id":"2577315288","title":"AIA: \"Softness persists at architecture firms\" in September","url":"https://stock-news.laohu8.com/highlight/detail?id=2577315288","media":"Calculated Risk","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577315288?lang=en_us&edition=fundamental","pubTime":"2025-10-22 15:46","pubTimestamp":1761119160,"startTime":"0","endTime":"0","summary":"From the AIA: ABI September 2025: Weakness persists at architecture firmsThe AIA/Deltek Architecture Billings Index  score of 43.3 for the month is the softest reading since April and represents an increase in the share of firms reporting a decrease from August. In addition, inquiries into new projects remained flat for the second consecutive month, following growth over the summer, and the value of newly signed design contracts decreased for the 19th consecutive month. All of these indicators mean that the soft conditions that many architecture firms have been experiencing since late 2022 are likely to persist for the foreseeable future.The ABI serves as a leading economic indicator that leads nonresidential construction activity by approximately 9-12 months.emphasis added Northeast ; Midwest ; South ; West . This index usually leads CRE investment by 9 to 12 months, so this index suggests a slowdown in CRE investment throughout","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"calculatedriskblog_highlight","url":"https://www.calculatedriskblog.com/2025/10/aia-softness-persists-at-architecture.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.calculatedriskblog.com/2025/10/aia-softness-persists-at-architecture.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"calculatedriskblog_highlight","symbols":["BK4087","AIA","CRE","ABI"],"gpt_icon":0},{"id":"2575296609","title":"Promising Phase 1b Results for ABI-5366 Drive Buy Rating for Assembly Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2575296609","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575296609?lang=en_us&edition=fundamental","pubTime":"2025-10-14 18:15","pubTimestamp":1760436925,"startTime":"0","endTime":"0","summary":"Analyst Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Assembly Biosciences and keeping the price target at $50.00. Patrick Trucc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-phase-1b-results-for-abi-5366-drive-buy-rating-for-assembly-biosciences-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-phase-1b-results-for-abi-5366-drive-buy-rating-for-assembly-biosciences-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ASMB","ABI"],"gpt_icon":0},{"id":"2574017554","title":"Assembly Biosciences Presents Interim Phase 1b Data for HSV Helicase-Primase Inhibitor Candidate ABI-5366 at the 38th Congress of the International Union Against Sexually Transmitted Infections (IUSTI)- Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2574017554","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574017554?lang=en_us&edition=fundamental","pubTime":"2025-10-10 20:00","pubTimestamp":1760097600,"startTime":"0","endTime":"0","summary":"– Late-breaking oral presentation highlights interim Phase 1b data reported earlier this year for two cohorts in participants with recurrent genital herpes – – Statistically significant reductions in ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/10/3164831/16259/en/Assembly-Biosciences-Presents-Interim-Phase-1b-Data-for-HSV-Helicase-Primase-Inhibitor-Candidate-ABI-5366-at-the-38th-Congress-of-the-International-Union-Against-Sexually-Transmitt.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","ABI","ASMB","HDV","BK4139","BK4588"],"gpt_icon":0},{"id":"2572776555","title":"Route1 Inc. Enhances ABI Software with New Revenue and Parking Capabilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2572776555","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572776555?lang=en_us&edition=fundamental","pubTime":"2025-10-02 00:38","pubTimestamp":1759336682,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Route1 Inc ( ($TSE:ROI) ). Route1 Inc. has announced the release of version 3.5 of its Actionable Business Inte...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/route1-inc-enhances-abi-software-with-new-revenue-and-parking-capabilities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/route1-inc-enhances-abi-software-with-new-revenue-and-parking-capabilities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ROIUF","ABI"],"gpt_icon":0},{"id":"2570033815","title":"AIA: \"Softness persists at architecture firms\" in August","url":"https://stock-news.laohu8.com/highlight/detail?id=2570033815","media":"Calculated Risk","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570033815?lang=en_us&edition=fundamental","pubTime":"2025-09-24 16:50","pubTimestamp":1758703800,"startTime":"0","endTime":"0","summary":"From the AIA: ABI August 2025: Softness persists at architecture firmsThe AIA/Deltek Architecture Billings Index  score was 47.2 for the month of August 2025. The share of firms reporting declining billings in August fell modestly from July, but overall, most firms continue to report a downward trajectory. In addition, inquiries softened in August and were essentially flat, after small increases over the previous three months. In addition, the value of new design contracts declined for the 18th consecutive month, the longest period of decline since we started collecting this data 15 years ago. This year has seen generally soft inquiries into new projects and a steady decrease in the value of newly signed design contracts, as clients remain cautious about committing to new projects. Without new work on the horizon, many firms will likely continue to experience declining billings in the coming months.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"calculatedriskblog_highlight","url":"https://www.calculatedriskblog.com/2025/09/aia-softness-persists-at-architecture.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.calculatedriskblog.com/2025/09/aia-softness-persists-at-architecture.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"calculatedriskblog_highlight","symbols":["ABI","AIA","BK4087","CRE"],"gpt_icon":0},{"id":"2569763272","title":"OSL Group Completes Acquisition of Licensed Indonesian Exchange Koinsayang","url":"https://stock-news.laohu8.com/highlight/detail?id=2569763272","media":"Blockbeats","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569763272?lang=en_us&edition=fundamental","pubTime":"2025-09-23 11:44","pubTimestamp":1758599040,"startTime":"0","endTime":"0","summary":"BlockBeats News, September 23rd. OSL Group announced that the company has acquired the licensed digital asset exchange platform Koinsayang in Indonesia through the issuance of approximately 9.2662 mil","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"theblockbeats_live","url":"https://www.theblockbeats.info//en/flash/313433","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/313433","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["ABI"],"gpt_icon":0},{"id":"2564325526","title":"UK Insurers Gain Insight into Carbon Footprint of Claims with New Verisk Calculator","url":"https://stock-news.laohu8.com/highlight/detail?id=2564325526","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564325526?lang=en_us&edition=fundamental","pubTime":"2025-09-04 14:10","pubTimestamp":1756966200,"startTime":"0","endTime":"0","summary":"The Carbon Trust assures Verisk tool delivering industry-first emissions tracking for property claimsLondon, UK, Sept.  04, 2025  (GLOBE NEWSWIRE) -- Verisk (Nasdaq: VRSK), a leading data and analytic","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/04/3144196/0/en/UK-Insurers-Gain-Insight-into-Carbon-Footprint-of-Claims-with-New-Verisk-Calculator.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4511","BK4124","INAQU","MGA","ABI"],"gpt_icon":0},{"id":"2557521710","title":"Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Study of Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366 Showing Reductions in Viral Shedding Rate and Genital Lesion Rate in Recurrent Genital Herpes","url":"https://stock-news.laohu8.com/highlight/detail?id=2557521710","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557521710?lang=en_us&edition=fundamental","pubTime":"2025-08-08 20:00","pubTimestamp":1754654400,"startTime":"0","endTime":"0","summary":"– 94% reduction in HSV-2 shedding rate and 98% reduction in high viral load shedding rate, both statistically significant, observed in cohort evaluating 350mg weekly oral dose compared to placebo over","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/08/3130113/16259/en/Assembly-Biosciences-Reports-Positive-Interim-Results-from-Phase-1b-Clinical-Study-of-Long-Acting-Helicase-Primase-Inhibitor-Candidate-ABI-5366-Showing-Reductions-in-Viral-Shedding.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABI","BK4181","BK4588","BK4585","BK4139","BK4213","PK","BK4218","SD","ASMB","HDV"],"gpt_icon":0},{"id":"2557077723","title":"Assembly Biosciences Reports Interim Phase 1a Data from Clinical Study of Oral Entry Inhibitor Candidate ABI-6250 for Hepatitis Delta Virus","url":"https://stock-news.laohu8.com/highlight/detail?id=2557077723","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557077723?lang=en_us&edition=fundamental","pubTime":"2025-08-07 04:05","pubTimestamp":1754510700,"startTime":"0","endTime":"0","summary":"– Data to date in single- and multiple-ascending dose cohorts of healthy participants demonstrate a four-day half-life for ABI-6250, supporting target daily oral dosing profile and dose-dependent elev","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/06/3128674/16259/en/Assembly-Biosciences-Reports-Interim-Phase-1a-Data-from-Clinical-Study-of-Oral-Entry-Inhibitor-Candidate-ABI-6250-for-Hepatitis-Delta-Virus.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4218","LU1878469433.USD","BK4139","ABI","ASMB","BK4181","BK4585","BK4599","PK","BK4588","HDV","ALT"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}]}}